Hyoscyamine as a Novel Treatment for Intestinal Pseudo-obstruction in Myotonic Dystrophy Type 1 (P10-11.015)

Authors

Jacinda B. Sampson (ORCID: https://orcid.org/0000-0002-4991-6496)
Stephanie Roses (ORCID: https://orcid.org/0000-0002-4154-4958)
John Day (ORCID: https://orcid.org/0000-0002-0086-9529)
Linda Nguyen (ORCID: https://orcid.org/0000-0001-8620-7907)

Institutions

Neurology, Inc (US)
Stanford University (US)

Publication Details

Journal: Neurology
Published: 2025-04-07
DOI: https://doi.org/10.1212/wnl.0000000000212684
Citations: 2
Primary Topic: Genetic Neurodegenerative Diseases
Type: article
Field-Weighted Citation Impact: 1.82

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Hyoscyamine as a Novel Treatment for Intestinal Pseudo-obstruction in Myotonic Dystrophy Type 1 (P10-11.015)

Jacinda B. Sampson, Stephanie Roses, John Day, Linda Nguyen

Apr 7, 2025

2 citations

Neurology

Genetic Neurodegenerative Diseases

1.82

article

Hyoscyamine as a Novel Treatment for Intestinal Pseudo-obstruction in Myotonic Dystrophy Type 1 (P10-11.015)

Jacinda B. Sampson, Stephanie Roses, John Day, Linda Nguyen

April 7, 2025article en

2 citations

Abstract

No abstract available for this paper.

NeurologyVol. 104(7_Supplement_1)

Neurology, Inc (US), Stanford University (US)

Zero hunger

Openalex Percentile: Top 17%

Genetic Neurodegenerative Diseases

1.82

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.